Invitrogen is one of the leading Biotech companies in the world. Incorporated in 1987， California， American， Invitrogen has branches in central countries like Canada， Japan， Singapore， South Korean， and other 24 countries as well as regions. Up to 2004， its revenues have surpassed $1 billion. As a key partner in the global life science community， we provide products and services that support academic， government research institutions， pharmaceutical and biotechnology as well. Customers around the world have been a focus throughout our products， using them at every step along their path of discovery， including the discovery of the AIDS virus， advancements in Caner treatment and so on. Every day， with over 4，500 employees and 20，000 products， we focus on breakthrough innovations in all major areas of biological discovery， including functional genomics， proteomics， bioinformatics and cell biology， trying to better the human condition and ultimately improve the living experience. In China， we are expanding aggressively through acquisition and investment of new facilities. Currently we have over 200 staffs in china， with business operation in Shanghai， Beijing， Guangzhou and other cities.